Patrick Donnelly
Stock Analyst at Citigroup
(5.00)
# 10
Out of 4,869 analysts
329
Total ratings
49.71%
Success rate
162.15%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Downgrades: Neutral | $50 → $40 | $38.08 | +5.04% | 16 | May 22, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $236.74 | +47.84% | 15 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $250.08 | +39.96% | 15 | May 2, 2025 | |
| ILMN Illumina | Maintains: Neutral | $90 → $85 | $90.49 | -6.07% | 16 | Apr 7, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $290 → $215 | $146.48 | +46.78% | 9 | Apr 7, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,400 | $1,153.93 | +21.32% | 13 | Apr 7, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $20 → $15 | $10.81 | +38.76% | 12 | Mar 4, 2025 | |
| AVTR Avantor | Maintains: Neutral | $22 → $18 | $13.57 | +32.65% | 8 | Mar 4, 2025 | |
| TECH Bio-Techne | Maintains: Neutral | $80 → $70 | $49.89 | +40.31% | 11 | Mar 4, 2025 | |
| HOLX Hologic | Maintains: Neutral | $80 → $70 | $64.48 | +8.56% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $210 | $154.73 | +35.72% | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $650 → $570 | $397.88 | +43.26% | 19 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $179.43 | +3.10% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $155 → $175 | $147.45 | +18.68% | 20 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $196.39 | +34.94% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $5.32 | +332.33% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $44 → $50 | $28.03 | +78.38% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $11.39 | +75.59% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $53.01 | +41.48% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $115.56 | +42.78% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $49.14 | -8.42% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $23.29 | +20.22% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $94.99 | +52.65% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $46.76 | +32.16% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $342.63 | -12.44% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.01 | +199.50% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $1.92 | +43.23% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $261.88 | -0.72% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $6.42 | -6.54% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $4.92 | +550.41% | 2 | Nov 30, 2018 |
Bruker
May 22, 2025
Downgrades: Neutral
Price Target: $50 → $40
Current: $38.08
Upside: +5.04%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $236.74
Upside: +47.84%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $250.08
Upside: +39.96%
Illumina
Apr 7, 2025
Maintains: Neutral
Price Target: $90 → $85
Current: $90.49
Upside: -6.07%
ICON Public Limited Company
Apr 7, 2025
Maintains: Buy
Price Target: $290 → $215
Current: $146.48
Upside: +46.78%
Mettler-Toledo International
Apr 7, 2025
Upgrades: Buy
Price Target: $1,400
Current: $1,153.93
Upside: +21.32%
10x Genomics
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $10.81
Upside: +38.76%
Avantor
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $13.57
Upside: +32.65%
Bio-Techne
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $49.89
Upside: +40.31%
Hologic
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $64.48
Upside: +8.56%
Mar 4, 2025
Maintains: Neutral
Price Target: $225 → $210
Current: $154.73
Upside: +35.72%
Mar 4, 2025
Maintains: Neutral
Price Target: $650 → $570
Current: $397.88
Upside: +43.26%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $179.43
Upside: +3.10%
Mar 4, 2025
Upgrades: Neutral
Price Target: $155 → $175
Current: $147.45
Upside: +18.68%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $196.39
Upside: +34.94%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $5.32
Upside: +332.33%
Dec 11, 2024
Upgrades: Buy
Price Target: $44 → $50
Current: $28.03
Upside: +78.38%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $11.39
Upside: +75.59%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $53.01
Upside: +41.48%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $115.56
Upside: +42.78%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $49.14
Upside: -8.42%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $23.29
Upside: +20.22%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $94.99
Upside: +52.65%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $46.76
Upside: +32.16%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $342.63
Upside: -12.44%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $3.01
Upside: +199.50%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $1.92
Upside: +43.23%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $261.88
Upside: -0.72%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $6.42
Upside: -6.54%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $4.92
Upside: +550.41%